Hua Medicine operates as a drug development company. The Company develops and sells glucokinase activator and other products. Hua Medicine markets its products throughout China.

Notification Letter To Non-Registered Shareholders And Request Form

Notification Letter To Registered Shareholders And Reply Form

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2024

Announcements and Notices - [Interim Results]

Interim Results Announcement For
The Six Months Ended June 30, 2024

Announcements and Notices - [Date of Board Meeting]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hua Medicine Ltd (2552 HK)

Notification Letter To Non-Registered Shareholders And Request Form

Notification Letter To Registered Shareholders And Reply Form

Interim Report 2024

Interim Results Announcement For The Six Months Ended June 30, 2024

Date Of Board Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)